Blog

Posted: 27 march 2026

b.well, Perplexity partner for AI-powered personalized health answers

b.well Connected Health, which offers a connected health data network, is partnering with AI-enabled conversational search engine Perplexity to allow Perplexity users to authorize access to their medical records and ask personalized health questions informed by their individual health history. …

Innovation in treating obsessive-compulsive disorder will not solve the care gap

Obsessive-compulsive disorder (OCD) remains one of psychiatry’s most disabling conditions, affecting about 1-2% of the population. People with OCD have an 82% increase in all cause mortality compared with unnafected matched people from the general population, with suicide being a major contributor.…

Servier to acquire Day One, maker of pediatric cancer drug, for $2.5B

The French pharma company Servier said Friday that it would buy Day One Biopharmaceuticals, the maker of a drug for childhood brain tumors, in a deal worth roughly $2.5 billion. Read more here.

First Targeted Bladder Cancer Treatment Shows Promising Phase I Results

In a potential win for targeted therapy in bladder cancer, Johnson & Johnson announced results from a Phase I study of erdafitinib (Erda-iDRS) in patients with the intermediate-risk non-muscle-invasive form of the disease. Read more here.

Turquoise Health raises $40M to power healthcare contracts, payments

Turquoise Health, a healthcare pricing and payment platform, secured $40 million in series C funding. Read more here.

AI-powered imaging tracks wound healing under the skin in real time

Based on research completed as part of a multi-year collaboration with Nokia Bell Labs, biomedical engineers at Duke University are developing a solution. Using a custom-built optical coherence tomography (OCT) imaging system together with artificial intelligence (AI) models grounded in…

AI Closes Data Gaps for Rare ICU Conditions

Rare conditions in the ICU include both formally classified rare diseases and conditions that occur infrequently in critical care settings. These patients often face delayed diagnosis, limited specialist expertise and complex multisystem involvement, all of which contribute to poorer outcomes…

Artificial intelligence (AI) technologies to help detect or characterise colorectal polyps

NICE has developed tools and resources, in association with relevant stakeholders, to help organisations put this guidance into practice. The evidence generation plan gives further information on the prioritised evidence gaps and outcomes, Read more here.

Six innovations with a mission to reduce hospital admissions for people living with dementia

A recent dementia webinar showcased six innovations that aim to reduce avoidable hospital admissions and improve care for people living with dementia (PLWD). The webinar was a collaboration between Health Innovation Networks in the South East. Check it out here.

German Start-Up Remi Health raises €5m to scale Diagnostics-as-a-Service platform across Europe

Remi Health, the Diagnostics-as-a-Service platform, today announced it has secured an oversubscribed €3 million seed round, bringing total funding to €5 million. The round was led by IBB Ventures, with participation from Catalpa Ventures, MSD Global Health Innovation Fund and…

GSK sells liver disease drug candidate to Alfasigma for $690m

Italy-based Alfasigma will acquire worldwide development, manufacturing, and commercialisation duties for linerixibat, GSK’s ileal bile acid transporter (IBAT) inhibitor being developed for cholestatic pruritus in primary biliary cholangitis (PBC). Read more here.

Next-generation medical drone cuts emergency response times

The Swedish company Everdrone is launching a newly developed drone (E3) designed to enable both more frequent and faster deployments to emergency calls. The drone can also be equipped to carry both defibrillators and other emergency medical equipment. Read more…

Get Involved

On the day